戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 D-19 antigens (spike S1, spike S1S2, and the nucleocapsid protein).
2 ells specific for influenza hemagglutinin or nucleocapsid protein.
3 thin the 65 C-terminal amino acids of the MV nucleocapsid protein.
4  ZBDs, such as those that occur in the HIV-1 nucleocapsid protein.
5 fect levels of S segment RNAs or the encoded nucleocapsid protein.
6 erminal domain of the SARS coronavirus (CoV) nucleocapsid protein.
7  most epitopes were located in ORF1ab or the nucleocapsid protein.
8 S1 fragment and T-cell responses against the nucleocapsid protein.
9 enomic RNA tightly encapsidated by the viral nucleocapsid protein.
10 ated RNase H, R sequence homology, and viral nucleocapsid protein.
11 iption, E10G, prevented interaction with the nucleocapsid protein.
12 lso prevented M2-1 from interacting with the nucleocapsid protein.
13 inc knuckle of the Mason-Pfizer monkey virus nucleocapsid protein.
14 ssay and were specific for the measles virus nucleocapsid protein.
15     The M2-1 protein also interacts with the nucleocapsid protein.
16 RNA genome tightly encapsidated by the viral nucleocapsid protein.
17 prior to the gene encoding the measles virus nucleocapsid protein.
18 ites to produce sgmRNA 7, encoding the viral nucleocapsid protein.
19 usion to cells, protease, integrase, and the nucleocapsid protein.
20 on between the coronavirus M protein and the nucleocapsid protein.
21 ial cleavage occurs between the viral p2 and nucleocapsid proteins.
22 terminal zinc-binding peptide from the HIV-1 nucleocapsid protein (10(-8)M</=K(d)(Co)</=10(-7)M; 10(-
23 benzamides (DISeBAs) as novel HIV retroviral nucleocapsid protein 7 (NCp7) inhibitors.
24                                        HIV-1 nucleocapsid protein, a domain of Gag, can bind to oligo
25 g assay could be demonstrated before day 12; nucleocapsid protein Abs emerged less consistently.
26             We also show that the hantavirus nucleocapsid protein accumulates in P bodies, where it s
27                                          The nucleocapsid protein amino acid sequence variability amo
28  manner, as did human immunodeficiency virus nucleocapsid protein, an established chaperone.
29 oth IgM and IgG antibodies against the viral nucleocapsid protein and (2) a neutralizing antibody res
30 ments, suggesting a relationship between the nucleocapsid protein and activation of the SL1 dimerizat
31        This influence was augmented by viral nucleocapsid protein and additional reverse transcriptas
32                      Vimentin bound to PRRSV nucleocapsid protein and anti-vimentin antibodies showed
33                            Interestingly, if nucleocapsid protein and APO3G are present in the same r
34 mic RNA completely encapsidated by the viral nucleocapsid protein and associated with the viral polym
35 mic RNA segments, each sheathed by the viral nucleocapsid protein and bound by the RNA-dependent RNA-
36 t of the nuclear localization signals in the nucleocapsid protein and distinct inserts in the spike g
37 s of the human immunodeficiency virus type 1 nucleocapsid protein and for the moloney murine leukemia
38                  Tightly packed complexes of nucleocapsid protein and genomic RNA form the core of vi
39                                     The TSWV nucleocapsid protein and human cytomegalovirus glycoprot
40 vestigation and characterization of the PEDV nucleocapsid protein and its possible link to cell cultu
41 ted in cytoplasmic bodies that contain viral nucleocapsid protein and nucleic acids.
42 genes to assess the abilities of Phlebovirus nucleocapsid protein and RNA-dependent RNA polymerase to
43 generation of CTL to limited epitopes on the nucleocapsid protein and that infection also results in
44                      Recognition between the nucleocapsid protein and the E2 protein was explored in
45 cle and provide signals for encapsidation by nucleocapsid protein and the promoters for RNA transcrip
46 -strand RNA virus is assembled with a single nucleocapsid protein and the viral genomic RNA.
47 xed with an MHV polymerase gene product, the nucleocapsid protein and the viral RNA.
48 roteins on their surface, but do not contain nucleocapsid protein and viral nucleic acids.
49 e of both truncated and mutant Sindbis virus nucleocapsid proteins and a variety of cross-linking rea
50 The core is composed of a complex of the NC (nucleocapsid) protein and genomic RNA, surrounded by a s
51 e salt concentration, presence or absence of nucleocapsid protein, and nature of the blunt-ended dupl
52 to that seen in mice immunized with the SARS nucleocapsid protein, and poor protection against a nonl
53 ore, which consists of the RNA segments, the nucleocapsid protein, and the RNA-dependent RNA polymera
54 leic acid binding/chaperone functions of the nucleocapsid protein, and thus may in principle help reg
55 er fluorescent proteins along with filovirus nucleocapsid proteins, and may suggest that a general in
56 ing cells specific for the hemagglutinin and nucleocapsid proteins appeared in circulation in multipl
57 leavage site exposed on the apex of the HAZV nucleocapsid protein arm domain that is cleaved during H
58 studies reported here establish a hantavirus nucleocapsid protein as a new PKR inhibitor.
59 s that a helix structural element in the MuV nucleocapsid protein becomes open when the sequestered R
60 trand, and the interaction is independent of nucleocapsid protein binding.
61             Here we show that the hantavirus nucleocapsid protein binds with high affinity to the 5'
62 sequence polymorphism in an RNA encoding the nucleocapsid protein but not in the additional genomic R
63 psid motifs similar to retrovirus capsid and nucleocapsid proteins, but Ty3 lacks a matrix-like struc
64  derived from either the PIV5 or Nipah virus nucleocapsid protein C-terminal ends are sufficient to d
65 ag proteins consisting of the capsid protein-nucleocapsid protein (CA-NC) domains with short N-termin
66                  We also show that the HIV-1 nucleocapsid protein can increase synthesis through the
67                              Incubation with nucleocapsid protein causes this form to refold to a the
68              Here, we demonstrate that CCHFV nucleocapsid protein (CCHFV-NP) augments mRNA translatio
69 ell clones recognized the measles virus (MV) nucleocapsid protein, confirming that the antibody respo
70 brary to determine if epitopes within the MV nucleocapsid protein could be identified with SSPE brain
71 ies reported here reveal that the hantavirus nucleocapsid protein counteracts the PKR antiviral respo
72 onal Abs specific for the spike, matrix, and nucleocapsid proteins did not prevent recrudescence, dem
73 ers the cleavage specificity of RT; however, nucleocapsid protein does not appear to enhance PPT prim
74 tes in a critical interaction with the viral nucleocapsid protein early in infection.
75                                              Nucleocapsid protein enhanced the overall efficiency of
76               Sera were screened by MERS-CoV nucleocapsid protein enzyme-linked immunosorbent assay a
77                      Nevertheless, the viral nucleocapsid protein, expressed as a GFP:N fusion, co-lo
78  human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein flanked by Gag sequences (r-preNC)
79  virus replicons (VRPs) expressing spike and nucleocapsid proteins from MERS-CoV and other human and
80 yplex of a siRNA against the influenza viral nucleocapsid protein gene and PEI87 resulted in a 94% dr
81           The results showed that moving the nucleocapsid protein gene away from the single transcrip
82 the promoter-proximal position preceding the nucleocapsid protein gene.
83    Both the amino and carboxy termini of the nucleocapsid protein had been predicted to form trimers
84                   We suggest that hantaviral nucleocapsid protein has an active role in hantaviral re
85 diate contact between the virus envelope and nucleocapsid protein (HBcAg).
86                                         Five nucleocapsid protein homologues, the tegument protein ho
87 ce that seroreactivity using SARS-CoV-2 anti-nucleocapsid protein IgG and anti-spike IgM assays are g
88 Abs to the receptor-binding domain (RBD) and nucleocapsid protein in addition to conventional isotype
89 re, we found that MOV10 interacts with HIV-1 nucleocapsid protein in an RNA-dependent manner and is p
90 model is warranted to include a role for the nucleocapsid protein in cap acquisition and storage.
91    Although structures are available for the nucleocapsid protein in complex with RNA, and also for p
92 d single-stranded nucleic acids, such as the nucleocapsid protein in HIV and the RecA DNA repair prot
93   Here, we have investigated the role of the nucleocapsid protein in MHV-induced disease.
94 t M2-1 does not require interaction with the nucleocapsid protein in order to function during transcr
95  significant response to SARS-CoV-2 spike or nucleocapsid protein in the ELISPOT assay.
96 erization at 37 degrees C in the presence of nucleocapsid protein increased the yield of SL1-mediated
97 sence of cell nuclear proteins and the viral nucleocapsid protein increases virus amplification effic
98    Further studies revealed that Andes virus nucleocapsid protein inhibited PKR dimerization, a criti
99 s between the packaging domain RNA and viral nucleocapsid protein inside virion particles, and identi
100 of paramyxovirus particles depends on matrix-nucleocapsid protein interactions which enable efficient
101                          The multifunctional nucleocapsid protein is complexed with the genomic RNA,
102 approximately 10(5) M(-1), implying that the nucleocapsid protein is important in promoting dimerizat
103         Thus, the amino-terminal part of the nucleocapsid protein is probably insufficient to initiat
104 ure of the N-terminal domain of the MERS-CoV nucleocapsid protein (MERS-CoV N-NTD).
105 s(2)HisCys) ZBD of Mouse Mammary Tumor Virus nucleocapsid protein (MMTV NCp10) were resistant to reac
106 ts with PD and determined that measles virus nucleocapsid protein (MVNP) was expressed in 70% of thes
107 n absence of S, expression of M and E or the nucleocapsid protein N did not induce a detectable serum
108 monstrated that moving the gene encoding the nucleocapsid protein N to successively more promoter-dis
109  in the presence of transcripts encoding the nucleocapsid protein N.
110 enomic and antigenomic) to interact with the nucleocapsid protein (N protein) and the location of thi
111                                   Hantavirus nucleocapsid protein (N protein) binds to the 5' caps of
112                 Here we show that hantavirus nucleocapsid protein (N protein) interacts with RdRp in
113 rotein or M protein was colocalized with VSV nucleocapsid protein (N protein) outside the budding sit
114                    The multifunctional CCHFV nucleocapsid protein (N protein) plays a crucial role in
115                               The hantavirus nucleocapsid protein (N protein), which is encoded by th
116 nsists of the RNA genome encapsidated by the nucleocapsid protein (N protein).
117                  Recombinant polymerase (L), nucleocapsid protein (N) and a reporter minigenome expre
118 e-sense genomic RNA completely coated by the nucleocapsid protein (N) and associated by a phosphoprot
119 otein complex of the genomic RNA coated by a nucleocapsid protein (N) and associated with polymerase.
120 lex L-P and encapsidation complex (N-P) with nucleocapsid protein (N) and binding to N protein-encaps
121 ne the relationship of helicase to the viral nucleocapsid protein (N) and to sites of viral RNA synth
122                                   Hantavirus nucleocapsid protein (N) binds to host mRNA caps and req
123  highly conserved hydrophobic domains in the nucleocapsid protein (N) C terminus of Edmonston MV.
124                                   Hantavirus nucleocapsid protein (N) can replace the cellular cap-bi
125 possibility that the multivalent RNA-binding nucleocapsid protein (N) from severe acute respiratory s
126 antaviruses do not have matrix proteins, the nucleocapsid protein (N) has been proposed to play a key
127 VFV infection, we measured the production of nucleocapsid protein (N) in cells transfected with small
128  virus (VSV), is completely enwrapped by the nucleocapsid protein (N) in every stage of virus infecti
129                                   Hantavirus nucleocapsid protein (N) is encoded by the smallest S se
130                                          The nucleocapsid protein (N) of vesicular stomatitis virus a
131 e interpret to reflect the lack of the viral nucleocapsid protein (N) on the template.
132                              The coronavirus nucleocapsid protein (N) plays an essential structural r
133 anded RNA genome that is encapsidated by the nucleocapsid protein (N) to form a helical ribonucleopro
134 rovirus genome are encapsidated by the viral nucleocapsid protein (N) to form ribonucleoprotein (RNP)
135 -sense RNA genomes that are sequestered by a nucleocapsid protein (N) to form ribonucleoprotein (RNP)
136 anded RNA genome that is encapsidated by the nucleocapsid protein (N) to form the nucleocapsid (NC).
137                         Interaction of viral nucleocapsid protein (N) with this conserved sequence fa
138 the human respiratory syncytial virus (hRSV) nucleocapsid protein (N) with viral genomic RNA (gRNA).
139 tal structure of the CCHFV strain Baghdad-12 nucleocapsid protein (N), a potential therapeutic target
140  the large viral polymerase protein (L), the nucleocapsid protein (N), and the assembled nucleocapsid
141 and ORF7 had significant similarities to the nucleocapsid protein (N), glycoprotein (G), and polymera
142 he nonstructural proteins (NSs and NSm), the nucleocapsid protein (N), or the Gn glycoprotein.
143                              The coronavirus nucleocapsid protein (N), together with the large, posit
144 ranslation initiation mechanism, operated by nucleocapsid protein (N), which preferentially facilitat
145 nted RNA genome of RVFV is encapsidated by a nucleocapsid protein (N).
146 mRNAs by a novel mechanism mediated by viral nucleocapsid protein (N).
147  through packaging of the genomic RNA by the nucleocapsid protein (N).
148 c RNA is sequestered within a homopolymer of nucleocapsid protein (N).
149                We report that the SARS-CoV-2 nucleocapsid protein (N-protein) undergoes liquid-liquid
150 ses comprises a genomic RNA encased within a nucleocapsid protein (N-RNA), and associated with the RN
151  genome, which resides inside an oligomer of nucleocapsid protein (N-RNA).
152                                        Viral nucleocapsid proteins (N) function in both genome replic
153  genome (open reading frame 1ab [ORF1ab] and nucleocapsid protein [N]).
154  an ambisense coding strategy to express the nucleocapsid protein, N, and the nonstructural protein,
155  the promoter-proximal gene that encodes the nucleocapsid protein, N, moved to the second or fourth p
156                               The bunyavirus nucleocapsid protein, N, plays a central role in viral r
157  examined the site of expression of the BCCV nucleocapsid protein (NBCCV) in the absence of BCCV glyc
158      This interaction is mediated by the Gag nucleocapsid protein NC, and the N-terminal part of NC i
159                                        HIV-1 nucleocapsid protein (NC) also binds nucleic acids and h
160 vely, the nucleic acid chaperone activity of nucleocapsid protein (NC) can catalyze this destabilizat
161 an T-cell lymphotropic virus type 1 (HTLV-1) nucleocapsid protein (NC) chaperone activity compared to
162                 Here, we show that the HIV-1 nucleocapsid protein (NC) enhances this annealing by app
163 ency virus type 1 minus-strand transfer, the nucleocapsid protein (NC) facilitates annealing of the c
164  HIV-1 (human immunodeficiency virus type 1) nucleocapsid protein (NC) facilitates multiple nucleic a
165                                    The HIV-1 nucleocapsid protein (NC) facilitates this annealing.
166                                          The nucleocapsid protein (NC) from the mouse mammary tumor v
167                                    The HIV-1 nucleocapsid protein (NC) functions as a nucleic acid ch
168  known, previous studies have shown that HIV nucleocapsid protein (NC) greatly accelerates primer/tem
169            In this study we show that virion nucleocapsid protein (NC) has a role in expression of HI
170 the nucleic acid chaperone activity of HIV-1 nucleocapsid protein (NC) in reverse transcription: bloc
171 tion in HIV-1 was used to assess the role of nucleocapsid protein (NC) in strand transfer.
172 s the nucleic acid chaperone activity of the nucleocapsid protein (NC) in the minus-strand transfer s
173                                     Although nucleocapsid protein (NC) interferes with -sssDNA self-p
174                                        HIV-1 nucleocapsid protein (NC) is a nucleic acid chaperone pr
175  Human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein (NC) is a nucleic acid chaperone th
176      The human immunodeficiency virus type 1 nucleocapsid protein (NC) is a nucleic acid chaperone th
177                                        HIV-1 nucleocapsid protein (NC) is a nucleic acid chaperone, w
178  human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein (NC) is an essential protein for re
179                                              Nucleocapsid protein (NC) is known to influence primer e
180            Enhancement of strand exchange by nucleocapsid protein (NC) is proposed to occur during re
181                                          The nucleocapsid protein (NC) of HIV type 1 (HIV-1) is a nuc
182                                          The nucleocapsid protein (NC) of HIV type 1 is a nucleic aci
183                                          The nucleocapsid protein (NC) of HIV-1 is 55 amino acids in
184                                          The nucleocapsid protein (NC) of human immunodeficiency viru
185                                          The nucleocapsid protein (NC) of human immunodeficiency viru
186                               The retroviral nucleocapsid protein (NC) originates by cleavage of the
187  human immunodeficiency virus type-1 (HIV-1) nucleocapsid protein (NC) plays an important role in the
188  Human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein (NC) plays several important roles
189 fer step of HIV-1 reverse transcription, the nucleocapsid protein (NC) promotes annealing of the 3' '
190 rized deletion of both Cys-His motifs in RSV nucleocapsid protein (NC) reduced both the efficiency of
191 ng the concentration of dNTPs or addition of nucleocapsid protein (NC) reduced pausing and the genera
192 ons using HIV reverse transcriptase (RT) and nucleocapsid protein (NC) that allowed efficient synthes
193                The specific binding of HIV-1 nucleocapsid protein (NC) to the different forms assumed
194       Ribonuclease H (RNase H) cleavages and nucleocapsid protein (NC) were required for long-distanc
195 Psi is capable of binding to the cognate RSV nucleocapsid protein (NC) with high affinity (dissociati
196 s type 1 (HIV-1) reverse transcriptase (RT), nucleocapsid protein (NC), genomic RNA, and the growing
197 gement steps that are catalyzed by the HIV-1 nucleocapsid protein (NC), including for example, the an
198 rangement steps that are "chaperoned" by the nucleocapsid protein (NC), including minus-strand transf
199 steps that are catalyzed (chaperoned) by the nucleocapsid protein (NC), including the annealing of th
200 DP6-Gag), could bind to matrix protein (MA), nucleocapsid protein (NC), or entire DP6-Gag protein.
201            Interestingly, in the presence of nucleocapsid protein (NC), the 24 downstream bases are d
202                        Addition of the HIV-1 nucleocapsid protein (NC), the trans-acting viral factor
203  not only reverse transcriptase but also the nucleocapsid protein (NC), which functions as a nucleic
204 1 reverse transcription is chaperoned by the nucleocapsid protein (NC), which has been shown to facil
205 d rearrangements, which are catalyzed by the nucleocapsid protein (NC).
206       This preference was accentuated by HIV nucleocapsid protein (NC).
207 t to be composed mainly of the viral RNA and nucleocapsid protein (NC).
208 y stable linkage by the viral p7 form of the nucleocapsid protein (NC).
209 ibonucleoprotein (vRNP, composed of vRNA and nucleocapsid protein [NC]) is packaged into a conical ca
210 templates in the presence and absence of HIV nucleocapsid protein (NCp) was investigated.
211  was enhanced by increasing the ratio of the nucleocapsid protein NCp7 to mini c TAR DNA from 0 to 2.
212 tobenzamide thioester that targets the viral nucleocapsid protein NCp7, causing zinc ejection and pre
213  stem-loop structure brought on by the HIV-1 nucleocapsid protein NCp7.
214 uctural rearrangement activated by the HIV-1 nucleocapsid protein (NCp7) and considered to be associa
215 l molecule inhibitors of the interactions of nucleocapsid protein (NCp7) and psi-RNA.
216 uctural rearrangement catalyzed by the HIV-1 nucleocapsid protein (NCp7) and suggested to be associat
217 equires reverse transcriptase (RT) and HIV-1 nucleocapsid protein (NCp7) for proper viral replication
218                                        HIV-1 nucleocapsid protein (NCp7) is a double zinc-fingered pr
219                                    The HIV-1 nucleocapsid protein (NCp7) is a small basic protein wit
220                                    The HIV-1 nucleocapsid protein (NCp7) is a small, highly conserved
221 to a more stable extended dimer by the viral nucleocapsid protein (NCp7).
222 the nucleic acid chaperone activity of HIV-1 nucleocapsid protein (NCp7).
223                                    The HIV-1 nucleocapsid protein, NCp7, facilitates the use of human
224 e compared with earlier studies of the HIV-1 nucleocapsid protein, NCp7, that contains a single trypt
225 d here an AlloSwitch, binds the mature HIV-1 nucleocapsid protein, NCp7.
226 ven RNA stem-loops bound to the mature HIV-1 nucleocapsid protein, NCp7.
227 lls expressing the NBCCV and La Crosse virus nucleocapsid protein (NLACV) showed different intracellu
228 rotein (GP) alone or in combination with the nucleocapsid protein NP or with the cytokine adjuvant gr
229 duction is inhibited by coexpression of ANDV nucleocapsid protein (NP) and glycoprotein precursor (GP
230 in (L) and the phosphoprotein (P), while the nucleocapsid protein (NP) encapsulates the viral RNA gen
231      Using the 5' UTR of the influenza virus nucleocapsid protein (NP) mRNA as bait, we identified th
232                                          The nucleocapsid protein (NP) of mumps virus (MuV), a paramy
233                         Hantavirus encodes a nucleocapsid protein (NP) to encapsidate the genome and
234  must require a conformational change in the nucleocapsid protein (NP) to make the RNA accessible by
235               Both regions interact with the nucleocapsid protein (NP), an essential component of the
236 lymerase proteins (PB1, PB2, and PA) and the nucleocapsid protein (NP), is responsible for this stabi
237 viral mRNA synthesis, and requires the viral nucleocapsid protein (NP).
238 ctions of the two RNA-binding domains of the nucleocapsid protein of a model coronavirus, mouse hepat
239                    We report that FP25K is a nucleocapsid protein of both the budded virus (BV) and o
240                                          The nucleocapsid protein of hantaviruses encapsidates viral
241                                   The mature nucleocapsid protein of HIV-1, NCp7, and the NC domains
242                     The binding of NCp7, the nucleocapsid protein of human immunodeficiency virus typ
243  positive clones identified fragments of the nucleocapsid protein of MV, the cause of SSPE.
244                              Antibody to the nucleocapsid protein of SARS-CoV-2 is more sensitive tha
245                                          The nucleocapsid protein of simian immunodeficiency virus (S
246  N protein has a fold similar to that of the nucleocapsid protein of the porcine reproductive and res
247 array" or "zinc knuckle" motif common to the nucleocapsid proteins of nearly all known retroviruses.
248                Emerging models indicate that nucleocapsid proteins of other viruses can form biomolec
249                                          The nucleocapsid proteins of Sindbis virus and Ross River vi
250 cursor for the matrix (MA), capsid (CA), and nucleocapsid proteins of the mature virion.
251 d from the nucleotide sequences encoding the nucleocapsid protein--one targeting RSV A and the other
252  lines recognized one of two epitopes on the nucleocapsid protein: one epitope spanning amino acids 1
253  be easily adaptable to binding by the HIV-1 nucleocapsid protein or loop receptors.
254  structure, even in the absence of the HIV-1 nucleocapsid protein or other RNA chaperones.
255  AC141 or VP39, suggesting that either other nucleocapsid proteins or adaptor proteins may be require
256 n of noncovalent complexes between the HIV-1 nucleocapsid protein p7 (NC) and RNA hairpins SL2-SL4 of
257 ackaging signal and their complexes with the nucleocapsid protein p7 (NC) were probed by solvent-acce
258  human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein p7 (NCp7) and Escherichia coli Ada
259  human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein p7 (NCp7) with a variety of electro
260                                          The nucleocapsid protein polymerizes along the length of the
261 ture particle to form the matrix, capsid and nucleocapsid proteins present in the mature virion.
262  G (IgG) antibodies specific for recombinant nucleocapsid proteins (recN) from hCoVs 229E, NL63, OC43
263   We find that Moloney murine leukemia virus nucleocapsid protein reduces RNase H degradation and sli
264  interactions between the RNA genome and the nucleocapsid protein regulate the activity of vRdRp, whi
265                        In the absence of the nucleocapsid protein, relatively weak activity was obser
266 with the nucleophilic sulfur of the HIV-1 p7 nucleocapsid protein's zinc finger assembly to eject the
267 SANS data also demonstrated that the RNA and nucleocapsid protein share a closer interaction in the m
268 symptom onset, antibodies against SARS-CoV-2 nucleocapsid protein showed 100% sensitivity and 100% sp
269 tructures of amino-terminal fragments of the nucleocapsid protein showed the formation of intramolecu
270 ntly, we detected an expansion of SARS-CoV-2 nucleocapsid protein-specific Ab-secreting cells in all
271 three proteins bound both the HIV-1 and EIAV nucleocapsid protein specifically in vitro.
272 destly increased (threefold) by inclusion of nucleocapsid protein, suggesting an ancillary role for t
273 ibits relatively poor affinity for the HIV-1 nucleocapsid protein, suggesting that the bulge plays ot
274 caspase cleavage site, DQVD, within the HAZV nucleocapsid protein that is also conserved in CCHFV.
275 or target for neutralizing Abs) or the viral nucleocapsid protein that is known to be highly immunoge
276 ns near the C-terminal ends of paramyxovirus nucleocapsid proteins that are important for matrix prot
277                                          The nucleocapsid protein, the major RNA-binding domain of Ga
278 e protein S1 fragment, membrane protein, and nucleocapsid protein to induce virus-specific broad immu
279  of the remaining viral glycoproteins or the nucleocapsid protein to the apical membrane.
280 ntribute to N protein trimerization and that nucleocapsid protein trimers are hantavirus particle ass
281                             In addition, the nucleocapsid proteins VP39, FP25, and BV/ODV-C42 were al
282 ine antiserum raised against recombinant SNV nucleocapsid protein was utilized to localize viral anti
283         The PIV5 M protein (but not the PIV5 nucleocapsid protein) was found to be targeted for monou
284 ties of SSPE rAbs to these regions of the MV nucleocapsid protein were confirmed by binding to synthe
285                                RT and the p7 nucleocapsid protein were released more readily from vif
286 e Abbott Architect immunoassay targeting the nucleocapsid protein were run in 3 SARS-CoV-2 IgG immuno
287 deficient nuclear interactions with the SYNV nucleocapsid protein were unable to suppress transcripti
288                Modifications to envelope and nucleocapsid proteins were detected by changes in their
289 ond to peptides from the membrane, spike, or nucleocapsid proteins were more common in subjects who d
290     T cell responses to SARS-CoV-2 spike and nucleocapsid proteins were present in only 1 participant
291 hed in HIV-1, and viral RNA, RT, matrix, and nucleocapsid proteins were retained in HIV-1 but to a mu
292 bs specific for the viral spike, matrix, and nucleocapsid proteins were transferred into infected B-c
293  two RNA 3 consensus sequences, encoding the nucleocapsid protein, were found with 12.5% sequence div
294 a cavity between two globular domains of the nucleocapsid protein where the viral RNA is sequestered.
295      These guanines may be recognized by the nucleocapsid protein, which binds tightly to the G-bulge
296                                              Nucleocapsid protein, which can improve cDNA-acceptor in
297                        The presence of HIV-1 nucleocapsid protein, which promotes strand exchange, ha
298 iruses demonstrated that the viral spike and nucleocapsid proteins, which play important roles in MHV
299 istep event requiring the association of the nucleocapsid protein with nucleic acid and the subsequen
300 ranscriptase, protease, virus attachment, or nucleocapsid protein zinc fingers.

 
Page Top